Limitations of sweat conductivity determinations with Nanoduct analyzing system for rapid sweat testing in patients with cystic fibrosis

J. Barben, R. A. Ammann, M. C. Desax, M. H. Schoeni (St. Gallen, Bern, Switzerland)

Source: Annual Congress 2005 - Cystic fibrosis: genes, inflammation and more
Session: Cystic fibrosis: genes, inflammation and more
Session type: Thematic Poster Session
Number: 2571
Disease area: Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Barben, R. A. Ammann, M. C. Desax, M. H. Schoeni (St. Gallen, Bern, Switzerland). Limitations of sweat conductivity determinations with Nanoduct analyzing system for rapid sweat testing in patients with cystic fibrosis. Eur Respir J 2005; 26: Suppl. 49, 2571

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Diagnostic efficiency of sweat conductivity testing in cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015


Usefulness of impulse oscillometry, single breath diffusion and bodypletysmography for lung function assessment in patients with cystic fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 715s
Year: 2006

Characterisation of leaks during multiple breath washout and their influence on test results
Source: International Congress 2015 – Paediatric respiratory physiology
Year: 2015

Clinical utility of measuring ventilation inhomogeneity: cystic fibrosis
Source: International Congress 2014 – Clinical utility of multiple breath washout (MBW): why is assessing ventilation inhomogeneity important?
Year: 2014

Comparison of nanoduct versus macroduct sweat test for the diagnosis of cystic fibrosis in the newborn screening programme in Switzerland
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis
Year: 2012

Difficulty in diagnosis of patients who have cystic fibrosis like symptoms and borderline sweat test
Source: Eur Respir J 2006; 28: Suppl. 50, 716s
Year: 2006

CFTR biomarkers: time for promotion to surrogate end-point
Source: Eur Respir J 2013; 41: 203-216
Year: 2013



Volumetric capnography: a promising lung function test in cystic fibrosis?
Source: Virtual Congress 2020 – Respiratory physiology and sleep: from neonates to adults
Year: 2020




The assesment of aerosol solution lung deposition in cystic fibrosis patients
Source: Eur Respir J 2004; 24: Suppl. 48, 584s
Year: 2004

Impulse oscillometry in patients with cystic fibrosis: relationship to health status and conventional lung function measurements
Source: Eur Respir J 2005; 26: Suppl. 49, 260s
Year: 2005

Non-invasive estimation of intra-pulmonary gas exchange efficiency during incremental exercise in healthy adults and patients with interstitial pulmonary fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 407s
Year: 2003

Functional chloride secretion, CFTR-sequencing and transcript analysis in patients with inconclusive results in sweat test and CFTR-mutation screening
Source: Eur Respir J 2005; 26: Suppl. 49, 402s
Year: 2005

Differences in regional pulmonary function between children with cystic fibrosis and healthy children determined by electrical impedance tomography
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013

Electrical impedance tomography as a clinical monitoring tool in patients with cystic fibrosis
Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis
Year: 2020


Monitoring of tobramycin levels in patients with cystic fibrosis by finger-prick sampling
Source: Eur Respir J 2012; 39: 1537-1538
Year: 2012


Oscillatory resistances measurement is an useful and reliable test to assess bronchial obstruction and reversibility
Source: Eur Respir J 2004; 24: Suppl. 48, 575s
Year: 2004

Rapid and portable MBW measurements for clinical application of LCI in routine clinics
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016


Evaluation of the effectiveness of cyclical and constant current on sweat volume and stimulation for cystic fibroses diagnoses
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014

Ability of lung clearance index to track changes in a routine clinical CF setting
Source: International Congress 2015 – Paediatric respiratory physiology
Year: 2015

The effect of spirometry on multiple breath washout outcomes in children with cystic fibrosis
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018